Home › Markets › Health Care › PGNY

Progyny Inc. (PGNY)

PGNY trades on Nasdaq in Health Care, Misc Health and Biotechnology Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$27.39
-2.28% on the day
Market cap
$2.1B
Mid cap
Revenue · 2025
$1.3B
+10.4% on 2024
Net income · 2025
$58.5M
4.5% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerPGNY on Nasdaq
SectorHealth Care
IndustryMisc Health and Biotechnology Services
CountryUnited States
IPO year2019
SEC CIK0001551306
SEC industry codeServices-Misc Health & Allied Services, NEC
Incorporated inDE

Financials · 2025

LineValue
Revenue$1.3B
Net income$58.5M
Operating income$85.3M
Net margin4.5%
Operating margin6.6%
Revenue growth+10.4%
Cash$112.2M
Total assets$742.4M
P/E (computed)35.9×
P/S (computed)1.6×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42019-10-25
Latest annual report10-K2026-02-27
Latest quarterly / interim10-Q2026-08-07
Latest current report8-K2026-08-06
Latest proxyDEFA14A2026-04-10

Source: SEC EDGAR submissions feed, 928 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.1%
1 month+0.3%
3 months-12.6%
Year to date+8.5%
1 year+36.3%
From 52-week high-13.9%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Misc Health and Biotechnology Services

TickerCompanyPriceDayMarket cap
AGLagilon health inc.$85.90+0.48%$1.4B
SHCSotera Health Company$18.21+0.33%$5.2B
DVADaVita Inc.$182.08+0.17%$11.6B
FMSFresenius Medical Care AG$21.08-0.61%$11.8B
VMDViemed Healthcare Inc. Common Shares$9.61+0.10%$366.0M
PARKPark Dental Partners Inc.$19.59-3.31%$93.2M
CCELCryo-Cell International Inc.$4.30-4.44%$34.7M
MGRXMangoceuticals Inc.$0.3716-3.08%$8.3M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier